Biotech Archives - Page 87 of 795

1 minute read

Novavax Presents Data On Updated COVID-19 Vaccine And Progress To Date On Its COVID-19-Influenza Combination Vaccine Candidate At World Vaccine Congress 2024

April 1, 8:06 AM

Novavax, Inc. (NASDAQ:NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, will showcase continued progress on data from its updated COVID-19 vaccine (NVX-CoV2601) and provide an

NVAX

1 minute read

Milestone Pharmaceuticals To Present Data On Etripamil At The American College Of Cardiology And European Heart Rhythm Association Annual Conferences

By Benzinga Newsdesk

April 1, 8:02 AM

Milestone® Pharmaceuticals Inc. (NASDAQ:MIST) a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular medicines, today announced that it will present data on

MIST

3 minute read

Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More

By Lara Goldstein

March 30, 8:57 AM

Welcome to Benzinga’s psychedelic headlines roundup. This is our pick of must-read news items from the last two…

CMND

4 minute read

Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta’s Influence

By Lara Goldstein

March 29, 12:43 PM

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have…

ATAI

4 minute read

Atai Life Sciences Q4 And Full-Year 2023 Results: Steep Cash Drain Yet 2026 Target Remains, Update On Psychedelic Pipeline

By Lara Goldstein

March 29, 9:20 AM

Clinical-stage psychedelics biotech Atai Life Sciences (NASDAQ:ATAI) announced its consolidated financial results for the fourth quarter and full…

ATAI

4 minute read

Candel Therapeutics Announces Oral Presentation During The 5th Glioblastoma Drug Development Summit With Update On Phase 1b Clinical Trial Of CAN-3110 In Recurrent High-Grade Glioma; Expects To Initiate Investigational New Drug-Enabling Work In A Secon…

By Benzinga Newsdesk

March 28, 4:17 PM

The first cohort of patients were treated with multiple injections of CAN-3110 in the ongoing phase 1b clinical trial. The serial procedures were well tolerated without observed dose-limiting toxicity. A second

CADL

1 minute read

Enliven Therapeutics To Share Initial Proof Of Concept Data From Phase 1 Clinical Trial Of ELVN-001 And Host Virtual Key Opinion Leader Event On April 11, 2024

By Benzinga Newsdesk

March 28, 4:14 PM

Enliven Therapeutics, Inc. (Enliven or the Company) (NASDAQ:ELVN), a clinical-stage precision oncology company focused on the discovery and development of next-generation small molecule kinase inhibitors, today announced

ELVN

2 minute read

Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI Meets Primary Endpoint Of Progression-Free Survival For Patients With Pretreated KRASG12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer

By Benzinga Newsdesk

March 28, 4:12 PM

Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Locally Advanced or

BMY

3 minute read

Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant Depression

By Lara Goldstein

March 28, 4:09 PM

Partners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a Phase 2a…

ATAI

2 minute read

Scholar Rock Is A Potential M&A Target, Its Exploration of Obesity Market Garners Interest: Analyst

By Vandana Singh

March 28, 2:42 PM

Raymond James has initiated coverage on Scholar Rock Holding (NASDAQ:SRRK), supported by the potential value with a couple of key programs utilizing selective myostatin inhibition to

NVO